Heron Therapeutics Inc (HRTX)
2.12
+0.05
(+2.42%)
USD |
NASDAQ |
Oct 04, 16:00
2.125
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Shareholders Equity (Annual): -33.97M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -33.97M |
December 31, 2022 | 13.57M |
December 31, 2021 | 77.57M |
December 31, 2020 | 236.49M |
December 31, 2019 | 403.84M |
December 31, 2018 | 370.16M |
December 31, 2017 | 131.14M |
December 31, 2016 | -21.25M |
December 31, 2015 | 118.11M |
December 31, 2014 | 63.06M |
December 31, 2013 | 68.94M |
December 31, 2012 | 51.82M |
December 31, 2011 | 15.75M |
December 31, 2010 | 1.316M |
December 31, 2009 | 6.796M |
December 31, 2008 | 7.598M |
December 31, 2007 | 29.47M |
December 31, 2006 | 12.06M |
December 31, 2005 | 6.203M |
Date | Value |
---|---|
December 31, 2004 | 14.15M |
December 31, 2003 | 11.26M |
December 31, 2002 | 15.46M |
December 31, 2001 | 19.17M |
December 31, 2000 | 21.16M |
December 31, 1999 | 12.04M |
December 31, 1998 | 9.00M |
December 31, 1997 | 10.20M |
December 31, 1996 | 5.00M |
December 31, 1995 | 5.20M |
December 31, 1994 | 11.80M |
December 31, 1993 | 10.50M |
December 31, 1992 | 20.20M |
December 31, 1991 | 3.10M |
December 31, 1990 | 6.30M |
December 31, 1989 | 9.50M |
December 31, 1988 | 13.30M |
December 31, 1987 | 17.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-33.97M
Minimum
2023
403.84M
Maximum
2019
139.50M
Average
77.57M
Median
2021
Shareholders Equity (Annual) Benchmarks
Arcutis Biotherapeutics Inc | 88.67M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 39.70M |